From May 12-13 OIFE was represented by Alessandra Tolaccia at the iDR26 – the International Drug Repurposing Conference 2026 in Brussels. The conference was an inspiring gathering of researchers, clinicians, patient advocates, and industry leaders organized by the project REMEDi4ALL. From AI-driven discovery to patient-led innovation, the energy around faster, more accessible treatments is real. Beyond…
The year 2024 is history – and it will be a year to remember with pride for the OIFE. Thanks to a growing number of dedicated volunteers, we were represented in many different conferences and events during the year – both face to face and online. We co-hosted the big Remedi4All conference in Bologna in…
The 2nd Remedi4All multi-stakeholder meeting “Ensuring patient centricity in Osteogenesis imperfecta research” has taken place in Bologna on 13th June 2024. OIFE was represented by several representatives of the OI Community giving examples and highlighting the importance of patient engagement and patient centricity in OI research, design and follow up of clinical trials, treatments and…
Would you be interested in attending a conference about patient engagement in OI research in Bologna, Italy? The conference takes place on June 13th 2024. It is organized by the consortium Remedi4All in collaboration with OIFE, As.It.OI (Italian OI-association), ERN BOND (European Reference Network on Rare Bone Diseases) and EURORDIS (Rare Diseases Europe). Tickets are…
On the 6th and 7th of March 2024, the international conference iDR24 took place in the Modernist Campus at Sant Pau Hospital in Barcelona (Spain), organized by REMEDi4ALL, Beacon for Rare Diseases and MeRIT. More than 50 speakers from across this broad range of disciplines gathered to deep-dive into the evolving landscape of drug repurposing.…
The Remedi4All consortium & the MOI-A Trial (Losartan) Information provided by Claudia Fuchs, EURORDIS What is Remedi4All? The EU-funded multidisciplinary consortium REMEDi4ALL (Repurposing Medicines for All) has an ambition to establish a European research and innovation eco-system that facilitates fast and cost-effective patient-centric development and implementation of repurposed medicines, meeting high unmet medical needs in…
Interview with Nick Bishop, professor of paediatric bone diseases at the University of Sheffield, UK Who are you and what is your relationship to OI? My name is Nick Bishop and I am professor of paediatric bone diseases at the University of Sheffield in the UK. I’ve worked here for the last 25 years (nearly).…
